Literature DB >> 24922295

Current and evolving features in the clinical management of haemophilia.

Antonio Coppola1, Massimo Morfini2, Ernesto Cimino1, Antonella Tufano1, Anna M Cerbone1, Giovanni Di Minno1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24922295      PMCID: PMC4044810          DOI: 10.2450/2014.0043-14s

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  80 in total

Review 1.  Systematic review of the role of FVIII concentrates in inhibitor development in previously untreated patients with severe hemophilia a: a 2013 update.

Authors:  Massimo Franchini; Antonio Coppola; Angiola Rocino; Elena Santagostino; Annarita Tagliaferri; Ezio Zanon; Massimo Morfini
Journal:  Semin Thromb Hemost       Date:  2013-09-10       Impact factor: 4.180

Review 2.  Tailored versus standard dose prophylaxis in children with hemophilia A.

Authors:  Cristina Santoro; Erminia Baldacci; Caterina Mercanti; Maria Gabriella Mazzucconi
Journal:  Semin Thromb Hemost       Date:  2013-09-10       Impact factor: 4.180

Review 3.  Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats.

Authors:  Giovanni Di Minno; Mariana Canaro; James W Ironside; David Navarro; Carlo F Perno; Andreas Tiede; Lutz Guertler
Journal:  Semin Thromb Hemost       Date:  2013-09-12       Impact factor: 4.180

Review 4.  Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities.

Authors:  Antonio Coppola; Cristina Santoro; Massimo Franchini; Caterina Mannucci; Selene Mogavero; Angelo Claudio Molinari; Piercarla Schinco; Annarita Tagliaferri; Rita Carlotta Santoro
Journal:  Semin Thromb Hemost       Date:  2013-09-08       Impact factor: 4.180

Review 5.  Hemophilia a and hemophilia B: different types of diseases?

Authors:  Elena Santagostino; Maria Rosaria Fasulo
Journal:  Semin Thromb Hemost       Date:  2013-09-08       Impact factor: 4.180

6.  Treatment for life for severe haemophilia A- A cost-utility model for prophylaxis vs. on-demand treatment.

Authors:  A Farrugia; J Cassar; M C Kimber; M Bansal; K Fischer; G Auserswald; B O'Mahony; K Tolley; D Noone; S Balboni
Journal:  Haemophilia       Date:  2013-03-28       Impact factor: 4.287

7.  Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART).

Authors:  M J Manco-Johnson; C L Kempton; M T Reding; T Lissitchkov; S Goranov; L Gercheva; L Rusen; M Ghinea; V Uscatescu; V Rescia; W Hong
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 8.  Molecular approaches for improved clotting factors for hemophilia.

Authors:  Randal J Kaufman; Jerry S Powell
Journal:  Blood       Date:  2013-09-24       Impact factor: 22.113

9.  Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.

Authors:  A Gringeri; C Leissinger; P A Cortesi; H Jo; F Fusco; S Riva; B Antmen; E Berntorp; C Biasoli; S Carpenter; K Kavakli; M Morfini; C Négrier; A Rocino; W Schramm; J Windyga; B Zülfikar; L G Mantovani
Journal:  Haemophilia       Date:  2013-06-04       Impact factor: 4.287

10.  Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey.

Authors:  M Franchini; A Coppola; A Rocino; E Zanon; M Morfini; Arianna Accorsi; Anna Brigida Aru; Chiara Biasoli; Isabella Cantori; Giancarlo Castaman; Simone Cesaro; Carlo Ciabatta; Raimondo De Cristofaro; Grazia Delios; Giovanni Di Minno; Marco D'Incà; Alfredo Dragani; Cosimo Pietro Ettorre; Fabio Gagliano; Gabriella Gamba; Giorgio Gandini; Paola Giordano; Gaetano Giuffrida; Paolo Gresele; Caterina Latella; Matteo Luciani; Maurizio Margaglione; Marco Marietta; Maria Gabriella Mazzucconi; Maria Messina; Angelo Claudio Molinari; Lucia Dora Notarangelo; Emily Oliovecchio; Flora Peyvandi; Gavino Piseddu; Gina Rossetti; Vincenza Rossi; Elena Santagostino; Mario Schiavoni; Piercarla Schinco; Maria Luisa Serino; Annarita Tagliaferri; Sophie Testa
Journal:  Haemophilia       Date:  2014-03       Impact factor: 4.287

View more
  3 in total

1.  Haemophilia Centre Certification Systems: optional or optimal choice for healthcare systems?

Authors:  Gabriele Calizzani; Michael Makris; Pier Mannuccio Mannucci; Domenica Taruscio; Giuliano Grazzini; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

Review 2.  Management of Hemophilia in Older Patients.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

3.  Use of Continuous Veno-Venous Hemodialysis (CVVHD) in Treatment of a Polytrauma Patient with Severe Hemophilia A.

Authors:  Renata Zajączkowska; Joanna Zorska; Wojciech Serednicki; Anna Wrzosek; Jerzy W Wordliczek
Journal:  Am J Case Rep       Date:  2022-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.